We are live on
!
Find out more
ADAP
Adaptimmune Therapeutics
ADAP
ADAP
Delisted
ADAP was delisted on the 27th of October, 2025.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
1
RhumbLine Advisers
Boston,
Massachusetts
| $72 | – | – | – |
|
| 2 |
EF
2
Empirical Finance
Havertown,
Pennsylvania
| – | -$20.8K | -800,000 | Closed |
|
| 3 |
RG
3
Rathbones Group
Liverpool,
United Kingdom
| – | -$11.3K | -432,818 | Closed |
|
| 4 |
XT
4
XTX Topco
George Town,
Cayman Islands
| – | -$9.2K | -353,836 | Closed |
|
| 5 |
JAIC
5
Josh Arnold Investment Consultant
Edina,
Minnesota
| – | -$37.8K | -20,000 | Closed |
|
| 6 |
6
Simplex Trading
Chicago,
Illinois
| – | -$483 | -18,610 | Closed |
|
| 7 |
7
Barclays
London,
United Kingdom
| – | -$66 | -2,532 | Closed |
|